AMERICAN REBEL HOLDINGS INC (AREB): Nasdaq/NYSE listing notice — American Rebel receives Nasdaq delisting notice for failure to hold annual meeting

AMERICAN REBEL HOLDINGS INC

Nasdaq notice on Feb 28, 2024 for noncompliance with Listing Rule 5620(a) due to no annual meeting within 12 months of FY2022 end.
Company has until April 15, 2024 to submit a compliance plan to regain listing on Nasdaq Capital Market.
Compliance plan expects to hold annual meeting within 60 days of filing FY2023 10-K; Nasdaq may grant exception until June 28, 2024.
While plan is pending, AREB and AREBW securities continue to trade on Nasdaq.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

AMERICAN REBEL HOLDINGS INC received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a)

Exact text from the filing

February 28, 2024, the Registrant received a written notice from the Listing Qualifications department of The Nasdaq Stock Market stating that because the Company has not yet held an annual meeting of shareholders within 12 months of the end of the Registrant’s 2022 fiscal year end, it no longer complies with Nasdaq Listing Rule 5620(a) for continued listing on The Nasdaq Capital Market. The Registrant has until April 15, 2024, which is 45 days from the date of the notice, to submit a plan to regain compliance and, if Nasdaq accepts the plan, it may grant an exception of up to 180 calendar day

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

AMERICAN REBEL HOLDINGS INC filing history →

Source: SEC EDGAR

accession 0001493152-24-008696

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.